Acta Med. 2024, 67: 46-52
https://doi.org/10.14712/18059694.2024.19
Neonatal Jaundice: A Study of the Incidence in Children of Rh (D) Negative and 0 Rh (D) Positive Mothers
References
1. H, Adendorff J, Huisamen D, et al. The prevalence of neonatal jaundice and risk factors in healthy term neonates at National District Hospital in Bloemfontein. Afr J Prim Health Care Fam Med. 2018 Apr 12; 10(1): e1–e6.
<https://doi.org/10.4102/phcfm.v10i1.1582>
<PubMed>
2. Straňák Z, Janota J. Neonatolgie. 2nd edition. Praha: Mladá fronta, 2015.
3. Lissauer T, Clayden G. Neonatal medicine. In: Illustrated Textbook of Paeditrics. 4th edition. Mosby, Elsevier, 2011: 168–172.
4. Rennie JM, Kendall G. A manual of Neonatal Intensive Care. 5th edition. Taylor & Francis Ltd, 2013.
5. S, Baiya N, Maelhacharoenporn K, Puapornpong P. The Association of Breastfeeding Practices with Neonatal Jaundice. J Med Assoc Thai. 2017 Mar; 100(3): 255–61.
6. JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008 May; 48(5): 941–52.
<https://doi.org/10.1111/j.1537-2995.2007.01625.x>
7. M. Prevence Rh (D) aloimunizace u Rh (D) negativních žen. Prakt Gyn. 2008; 12(2): 100–103.
8. YM, Koelewijn JM, van Kamp IL, van der Bom JG, Oepkes D, de Haas M. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme. BJOG. 2016 May; 123(6): 955–63.
<https://doi.org/10.1111/1471-0528.13816>
9. S, Rahman K, Hedayati M. Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review Article. Iran J Public Health. 2016 May; 45(5): 558–68.
10. AA, Ansari MA, Mishra A, Jha SK. Outcome of Neonatal Jaundice in term neonates with ABO incompatibility at tertiary care center. Int J Contemp Pediatr. 2020 Oct; 7(10): 1973–1977.
<https://doi.org/10.18203/2349-3291.ijcp20203969>
11. M, Hammerman C, Vreman HJ, Wong RJ, Stevenson DK. Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates. J Pediatr. 2010 Nov; 157(5): 772–7.
<https://doi.org/10.1016/j.jpeds.2010.05.024>
<PubMed>
12. IMC, Smits-Wintjens VEHJ, van der Bom JG, van Klink JMM, Oepkes D, Lopriore E. Neonatal management and outcome in alloimmune hemolytic disease. Expert Rev Hematol. 2017 Jul; 10(7): 607–616.
<https://doi.org/10.1080/17474086.2017.1331124>
13. D, Ling LE, Krumme AA, Tjoa ML, Moise KJ Jr. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010. AJOG Glob Rep. 2023 Mar 24; 3(2): 100203.
<https://doi.org/10.1016/j.xagr.2023.100203>
<PubMed>
14. AK, Al-Khattabi GH. Hemolytic Disease of the Newborn: A Review of Current Trends and Prospects. Pediatric Health Med Ther. 2021 Oct 7; 12: 491–498.
<https://doi.org/10.2147/PHMT.S327032>
<PubMed>
15. M. Management těhotenství s rizikem rozvoje hemolytické nemoci plodu a novorozence. Postgrad Med. 2016; 18(4): 352–356.
16. M, Thurik FF, Koelewijn JM, van der Schoot CE. Haemolytic disease of the fetus and newborn. Vox Sang. 2015 Aug; 109(2): 99–113.
<https://doi.org/10.1111/vox.12265>
17. JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: final data for 2002. Natl Vital Stat Rep. 2003 Dec 17; 52(10): 1–113.
18. D, Kubánková H, Masopust J, Pejchalová A, Písačka M. Imunohematologická vyšetření v těhotenství a po porodu. Transfuze Hematol dnes. 16, 2010, No. 1: 1–20.
19. BK, Singh R, Bhatta NK, Karku A, Baral N. Risk of neonatal hyperbilirubinemia in babies born to ‘O’ positive mothers: A prospective cohort study. Kathmandu Univ Med J. 2009; 7(1): 11–15.
<https://doi.org/10.3126/kumj.v7i1.1758>
20. B, Scrape S, Markham KB. Anti-M Alloimmunization: Management and Outcome at a Single Institution. AJP Rep. 2017 Oct; 7(4): e205–e210.
